Carisma Therapeutics Inc - Margin operasi CARM

carismatx.com - logo grafis emiten CARM

Carisma Therapeutics (CARM) is facing financial losses and complexities in the development of cell-based therapies. High barriers to entry are established by gene modification patents and the requirement for a robust scientific foundation. A flawless reputation as a leader in solid tumor therapy attracts major partners. The operating margin trend illustrates the business recovery process, and -428.30 shows the current value of this metric.

Carisma Tx (CARM): Rentabilitas kegiatan operasi saka 28.04.2023 nganti 25.10.2025

Rincian analitis lan laporan data perusahaan Carisma Therapeutics (CARM)

- rega lan prakiraan konsensus rega:
Pambiji fundamental perusahaan:Carisma Therapeutics
Produk dadi Carisma Tx

Operating margin measures cost management efficiency by determining the share of profit from core operations before taxes and interest relative to total revenue. By analyzing operating margin trends on GURU.Markets, an investor assesses the resilience of the Carisma Therapeutics (CARM) business model, where a strong scientific reputation in solid tumor therapy should translate into optimized operating expenses and future profitability.

Pesaing langsung

ARGX (argenx N.V.) - Margin operasi|Rentabilitas dodolan operasi BioNTech Pharma BNTX|Margin dodolan operasi ABVX (ABIVAX)|Margin operasi ADMA Biologics, Inc. (ADMA)|Margin operasi PTGX (protagonist-inc.com)|IMVT: Rentabilitas dodolan miturut bathi operasi|KNSA - Rentabilitas operasi|GRFS: Rentabilitas operasi|ADPT (Adaptive Biotechnologies) - Margin dodolan operasi|Rentabilitas dodolan miturut bathi operasi CLDX|Margin dodolan operasi AUPH|BCRX (BioCryst Pharmaceuticals) - Rasio bathi operasi|Rentabilitas operasi Vera Pharma (VERA)|DNTH (Dianthus Therapeutics) - Tingkat bathi operasi|Pharvaris N.V. - Margin dodolan operasi|Tingkat bathi operasi ABCL|TRML: Margin dodolan operasi|PGEN (Precigen) - Rentabilitas dodolan miturut bathi operasi|pharming.com (PHAR) - Rentabilitas operasi|Nektar Corp (NKTR) - Margin operasi|UPB (upstreambio.com) - Margin operasi|ZBIO: Tingkat bathi operasi|Margin operasi IMNM|Rentabilitas kegiatan operasi Gossamer Bio Inc|Margin operasi KALV (KalVista Pharma)|SEPN (Septerna Pharma) - Margin bathi operasi|PVLA: Margin dodolan operasi|Margin bathi operasi SVRA|RIGL: Margin operasi|Rentabilitas dodolan miturut bathi operasi ANAB|ATXS (Astria Corp) - Margin operasi|Rentabilitas dodolan miturut bathi operasi ENGN (enGene Bio)|Margin operasi RAPT|Rentabilitas kegiatan operasi Aerovate Therapeutics|Rentabilitas operasi Aclaris Therapeutics Inc. ACRS|Rentabilitas kegiatan operasi Kyverna Therapeutics Inc. (KYTX)|TLSA - Rentabilitas operasi|CABA: Rentabilitas operasi|VTYX (Ventyx Biosciences, Inc.) - Margin dodolan operasi|THTX - Rentabilitas kegiatan operasi|AVTX (avalotx.com) - Margin operasi|Rentabilitas dodolan operasi Eledon Pharmaceuticals Inc. ELDN|Margin operasi AGEN|CLYM (Climb Bio, Inc.) - Tingkat bathi operasi|Rentabilitas operasi zurabio.com ZURA|ATYR - Margin dodolan operasi|Adagene Inc - Margin operasi|ImageneBio (IMA) - Margin dodolan operasi|Shattuck Therapeutics (STTK) - Rentabilitas operasi|Rentabilitas dodolan operasi Equillium Inc (EQ)|Margin dodolan operasi CNTB|Rentabilitas dodolan miturut bathi operasi IMUX (Immunic, Inc.)|Rentabilitas operasi Atara Biotherapeutics, Inc. (ATRA)|IFRX - Rentabilitas dodolan operasi|Rentabilitas kegiatan operasi XFOR|Rentabilitas kegiatan operasi Adicet (ACET)|CELU - Rentabilitas operasi|INMB (INmune Bio, Inc.) - Rentabilitas dodolan miturut bathi operasi|BRNS: Margin operasi|Kezar Life Sciences Inc. (KZR) - Margin operasi|Rentabilitas operasi SAB Biotherapeutics Inc|Margin operasi Akari Therapeutics, Plc|Rentabilitas operasi Enlivex Therapeutics Ltd (ENLV)|QTTB - Rentabilitas dodolan operasi|Margin operasi GOVX (GeoVax Corp)|Edesa Biotech (EDSA) - Rentabilitas dodolan operasi|iBio Corporation - Margin operasi|XTL Biopharmaceuticals (XTLB) - Margin dodolan operasi|BOLT: Margin operasi|Margin dodolan operasi HCW Biologics Inc.|Rentabilitas operasi Aptevo|Rentabilitas dodolan miturut bathi operasi AIM (AIM ImmunoTech, Inc.)|Margin operasi ADTX|Rentabilitas kegiatan operasi GRI Bio Corp|Margin operasi XRTX (XORTX Therapeutics Inc)|Vyome Holdings (HIND) - Rentabilitas dodolan operasi|Revelation Biosciences Corp - Margin operasi|INDP (Indaptus Therapeutics, Inc.) - Rentabilitas dodolan miturut bathi operasi|SCNI: Margin operasi|CALI - Rentabilitas kegiatan operasi|AFMD (Affimed N.V.) - Margin operasi|Rentabilitas operasi ALLK|Margin dodolan operasi HOOK (HOOKIPA Pharma, Inc.)|IGMS - Rentabilitas dodolan operasi|Rentabilitas operasi iTeos ITOS|Ocean Bio - Rentabilitas operasi|TC BioPharm Ltd - Margin operasi|Rentabilitas dodolan operasi thirdharmonicbio.com